IMMUNOLOGICAL DISORDERS AND CYTOKINE PROFILE IN SYSTEMIC AND LOCALIZED SCLEROSIS


Cite item

Full Text

Abstract

Aim. Comparative study of disorders in cellular immunity and cytokine profile in systemic and localized sclerosis (SS, LS). Material and methods. Parameters of cellular immunity and cytokine profile were examined in 58 systemic sclerosis patients (24 patients with SS, 34 patients with LS and 33 healthy donors). The examination protocol included assay of circulating immune complexes (CIC), serum cytokines (IL-1beta, IL-4, IL-6, TNF), DNA antibodies, assessment of oxygen-dependent and non-oxygen-dependent functions of circulating neutrophils and monocytes, identification of lymphocytic phenotype. Results. Elevated levels of CIC, proinflammatory cytokines in SS and LS, antibodies to native doublechain DNA in LS were found. Free radical oxidation of neutrophils in LS was higher only by one parameter, in SS by all spontaneous tests of neutrophils and monocytes. Non-oxygen-dependent metabolism of phagocytes was enhanced only in SS. Patients with LS and SS have subnormal count of lymphocytes CD3+, CD4+, CD11b+ in the presence of elevated count of lymphocytesCD8+, CD16+ as well as activation markers — CD19+, CD25+, CD95+ and HLA-DR+ cells. CD25+ lymphocytes count is higher in SS than in LS. Conclusion. The study of metabolism of circulating phagocytes, cytokine profile lymphocytic phenotype can be used for differential diagnosis of LS with SS.

About the authors

N V Romanova

Medical Academy, Yaroslavl

Email: n.v.romanova@mail.ru
д-р мед. наук, доц. каф. кожных и венерических болезней

N P Shilkina

Medical Academy, Yaroslavl

Email: shilkin39@mail.ru
д-р мед. наук, проф., зав. каф. пропедевтики внутренних болезней

E Yu Kaprelyants

Medical Academy, Yaroslavl

Email: trufalena@mail.ru
аспирант каф. кожных и венерических болезней

V A Romanov

Medical Academy, Yaroslavl

Email: microbyama@mail.ru
д-р мед. наук, проф., зав. каф. микробиологии с вирусологией и иммунологией

References

  1. Иванова С. М., Гусева Н. Г., Волков А. Н. и др. Антинуклеарные антитела при системной склеродермии. Рос. ревматол. 1998; 3: 20—27.
  2. Сучков С. В., Грачева Т. С., Дорофеев А. Е. и др. Современные аспекты аутоиммунных заболеваний кожи. Рос. журн. кож. и вен. бол. 2004; 2: 4—7.
  3. Sato S., Fujimoto M., Hasegawa M. et al. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Mol. Immunol. 2004; 41 (12): 1123—1133.
  4. Sato S., Kodera M., Hasegawa M. et al. Antinucleosome antibody is a major autoantibody in localized scleroderma. Br. J. Dermatol. 2004; 151 (6): 1182—1188.
  5. Dalkilic E., Delek K., Gullulu M. et al. Lymphocyte phenotypes in systemic sclerosis. Ann. Rheum. Dis. 1999; 58 (11): 719— 720.
  6. Sato S. B cell abnormalities and autoantibody production in systemic sclerosis. Nihon Rin-sho Meneki Gakkai Kaishi 2006; 29 (2): 73—84.
  7. Sato S., Hasegawa M., Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J. Dermatol. Sci. 2001; 27 (2): 140—146.
  8. Takehara K., Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology (Oxford) 2005; 44 (3): 274—279.
  9. Гусева Н. Г. Системная склеродермия. М.: Медицина; 1993.
  10. Хаитов Р. М., Пинегин Б. В., Истамов Х. И. Экологическая иммунология. М.: ВНИРО; 1995.
  11. Hardin J. A., Downs J. T. Isolation of human monocytes on reorienting gradients of percoll. J. Immunol. Met. 1981; 40: 1—6.
  12. Kurien Biji T., Scofield R. H. Autoimmunity and oxidatively modified autoantigens. Autoimmun. Rev. 2008; 7 (7): 567—573.
  13. Hardardottir H., van Helvoort H. A., Vonk M. C. et al. Exercise in systemic sclerosis intrensifies systemic inflammation and oxidative stress. Scand. J. Rheumatol. 2010; 39 (1): 63—70.
  14. Biondi R., Coaccioli S., Lattanzi S. et al. Oxidant/antioxidant status in patients with Raynaud’s disease. Clin. Ther. 2008; 159 (2): 77—81.
  15. Hasegawa M. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis. J. Dermatol. 2010; 37 (1): 3—10.
  16. Маянский А. Н., Пикуза О. И. Клинические аспекты фагицитоза. Казань: Магариф; 1993.

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies